The massive revenue beat and strong sequential acceleration signal rapidly accelerating commercial adoption of TULSA-PRO. Watch for the full Q3 report on November 5 for EPS, cash flow, and updated full-year guidance, which could be raised from the prior $25M target.
Price Chart
Executive Summary
Profound Medical announced preliminary Q3 2026 revenue of $9.8M-$10.0M, representing ~85-89% YoY growth and ~45-47% above the $6.78M Bloomberg consensus. This is a record-breaking quarter driven by strong commercial adoption of the TULSA-PRO platform, with gross margin again expected to exceed 70%. The filing is a preliminary revenue pre-announcement ahead of full Q3 results on November 5, 2026.
Key Financial Metrics
Key Facts
- Preliminary Q3 2026 revenue expected $9.8M to $10.0M, up ~85-89% YoY from $5.3M in Q3 2025
- Sequential growth of ~292-300% from $2.5M in Q2 2026
- Revenue approximately 45-47% above Bloomberg mean analyst consensus of $6.78M
- Gross margin expected to exceed 70% for Q3 2026
- Full Q3 2026 financial results to be reported on November 5, 2026
Financial Impact
Revenue beat of ~45-47% vs consensus ($6.78M), with record quarterly revenue of $9.8M-$10.0M
Risk Factors
- Preliminary and unaudited figures may differ from final results
- Company is still pre-profitable with operating losses; path to profitability depends on sustained revenue growth
- Dependence on continued TULSA-PRO adoption and payer coverage expansion
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001171843-26-006499 |
| Exhibit: exh_991.htm | 0001171843-26-006499 |
| Document: 0001171843-26-006499-index-headers.html | 0001171843-26-006499 |
| Document: 0001171843-26-006499-index.html | 0001171843-26-006499 |
| Document: 0001171843-26-006499.txt | 0001171843-26-006499 |
| 8-K Data (Synthetic) | 0001171843-26-006499 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 5d ago | 8-K | $5.56 | awaiting T+5 | — | $5.64 (+1.53%) |
Oct 14, 2026 13d ago | 8-K | $6.62 $5.69 | ▼ −14.05% | ▼ −14.50% | $5.64 (−14.73%) |
Oct 9, 2026 18d ago | 8-K | $6.90 $6.01 | ▼ −12.90% | ▼ −10.93% | $5.64 (−18.19%) |
Oct 7, 2026 20d ago | 8-K | $6.91 $6.31 | ▼ −8.68% | ▼ −8.41% | $5.64 (−18.31%) |
Sep 3, 2026 7w ago | 8-K | $6.89 $5.81 | ▼ −15.67% | ▼ −14.47% | $5.64 (−18.07%) |
Sep 3, 2026 7w ago | 8-K | $6.80 $5.97 | ▼ −12.21% | ▼ −11.06% | $5.64 (−16.99%) |
Aug 17, 2026 10w ago | 8-K | $6.55 $6.80 | ▲ +3.82% | ▲ +5.01% | $5.64 (−13.82%) |
Aug 17, 2026 10w ago | 8-K | $6.55 $6.80 | ▲ +3.82% | ▲ +5.01% | $5.64 (−13.82%) |
Jul 24, 2026 13w ago | 8-K | $7.26 $7.25 | ▼ −0.14% | ▼ −0.51% | $5.64 (−22.25%) |
Jul 15, 2026 14w ago | 8-K | $6.96 $6.99 | ▲ +0.43% | ▲ +1.41% | $5.64 (−18.89%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers